指南与共识传染病防控与疫情报告免疫规划

德国STIKO修订麻疹暴露后免疫球蛋白预防建议

Post-exposure prophylaxis for measles with immunoglobulins revised recommendations of the standing committee on vaccination in Germany.
指南 / 共识 · Vaccine · 2018-11-23

德国常设疫苗接种委员会(STIKO)基于国家参考中心对现有免疫球蛋白产品麻疹病毒中和能力的重新评估,修订了2001年麻疹暴露后使用免疫球蛋白的建议。新建议针对未受保护的高危人群(6月龄以下婴儿、易感孕妇和免疫缺陷患者),推荐暴露后尽快(最好6天内)单次静脉注射免疫球蛋白400 mg/kg体重。

要点

  • 暴露后尽快(最好6天内)单次静脉注射免疫球蛋白400 mg/kg体重。
  • 适用人群:6月龄以下婴儿、易感孕妇和免疫缺陷患者。
  • 免疫球蛋白中麻疹抗体浓度因人群免疫水平下降而降低。

核心结论

  • STIKO修订麻疹暴露后免疫球蛋白预防建议,推荐单次静脉注射400 mg/kg体重,最好在暴露后6天内实施。

研究设计与样本

  • STIKO重新评估现有数据及罗伯特·科赫研究所国家麻疹、腮腺炎、风疹参考中心对德国可用免疫球蛋白产品麻疹病毒中和能力的检测结果。

主要发现

  • 由于全球麻疹标准主动免疫的引入和病毒循环减少,人群麻疹病毒特异性IgG抗体水平下降,导致人血浆来源免疫球蛋白产品中麻疹病毒特异性抗体浓度降低。
  • 德国不常规检测免疫球蛋白产品的麻疹病毒中和能力,无官方数据关于德国可用免疫球蛋白各批次中麻疹病毒特异性IgG抗体浓度,且未规定麻疹病毒特异性IgG的最低要求水平。

关键数值与推荐

  • 推荐单次静脉注射免疫球蛋白400 mg/kg体重,暴露后尽快给药,最好在6天内。
  • 适用对象为6月龄以下婴儿、易感孕妇和免疫缺陷患者。

临床怎么用

  • 对麻疹暴露后的高危未受保护人群(6月龄以下婴儿、易感孕妇、免疫缺陷患者),应尽快(最好6天内)单次静脉注射免疫球蛋白400 mg/kg体重。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Passive immunisation with immunoglobulins as post-exposure prophylaxis after contact with measles is recommended by the German Standing Committee on Vaccination (STIKO) particularly for unprotected individuals at high risk of complications for whom active immunization is contraindicated, such as infants <6 months of age, immunocompromised patients and pregnant women. The efficacy of passive immunisation in preventing measles depends on how soon after exposure it is administered, the concentration of measles antibodies in the immunoglobulin products and dosage. Since the global introduction of standard active immunisation against measles and the concomitant reduction in virus circulation, the levels of measles virus (MV)-specific IgG antibodies in the population have dropped. Thus, the concentration of MV-specific antibodies in immunoglobulin products derived from human plasma donors has declined as the proportion of vaccinated donors has increased. The MV-neutralizing capacity of immunoglobulin products is not routinely tested in Germany. No official data exist on the concentrations of MV-specific IgG antibodies in individual batches of immunoglobulins available in Germany and the required minimum level for MV-specific IgG is not stipulated. The STIKO re-evaluated available data and measurements of MV-neutralizing capacities of available immunoglobulin (IgG) products in Germany at the National Reference Centre Measles, Mumps, Rubella at the Robert Koch Institute. Based on the findings, STIKO modified its previous recommendations on the post-exposure use of immunoglobulins (2001), especially with respect to risk groups, application and dosage. STIKO now recommends a single intravenous administration of immunoglobulins (400 mg/kg body weight) as soon as possible, preferably within six days, after exposure to measles, specifically for infants aged <6 months, susceptible pregnant women and immunocompromised patients.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Matysiak-Klose D, Santibanez S, Schwerdtfeger C, et al. Post-exposure prophylaxis for measles with immunoglobulins revised recommendations of the standing committee on vaccination in Germany. Vaccine. 2018. PMID: 30478003. doi:10.1016/j.vaccine.2018.10.070

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。